Empagliflozin improves left ventricular diastolic function in db/db mice without altering cardiac expression of enzymes relevant for ketone body or branched chain amino acid catabolism.

26 August 2018 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Targeting reverse remodelling in heart failure Pharmacotherapy ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by